Navigation Links
WuXi PharmaTech Announces Second Quarter 2008 Results
Date:8/13/2008

and as defined in the Private Securities Litigation Reform Act of 1995, including, among others, our anticipated net revenues for 2008; the favorable global trend in R&D outsourcing; our expected ability to continue to grow our revenues, despite a softening global economy, by meeting customer needs, expanding and evolving our services to serve as an integrated total solutions to broadening customer base and helping our partners improve the success of drug discovery and shorten the time of development; potential near-term lumpiness in our biologics business due to smaller clients issues with their cell line performance and funding pressures potentially offset by large pharmaceutical customer interest in biologics testing and manufacturing services in China--a capability we are moving to provide; and the ability of recent management additions to help drive company growth.

These forward-looking statements are not historical facts but instead represent only our belief regarding future events, many of which, by their nature, are inherently uncertain and outside of our control. Our actual results and financial condition and other circumstances may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements. For example, a softening global economy may adversely impact our business and R&D outsourcing trends; our smaller biologics clients may continue to face cell line performance and funding difficulties for longer than anticipated. We may be unable to successfully expand our capabilities to meet client needs (including offering biologics testing and manufacturing in China). In addition other factors that could cause our actual results to differ from what we currently anticipate include our limited operating history; failure to generate sufficient future cash flows or secure any required future financing on acceptable terms or at all; failure to retain key personnel; effective integration of product
'/>"/>

SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. WuXi PharmaTech Schedules 2007 Third Quarter Earnings Release on Monday, November 12, 2007
2. WuXi PharmaTech (NYSE: WX) CEO Honored with Ernst & Young Entrepreneur Of The Year China 2007 Award
3. WuXi PharmaTech Announces Third Quarter 2007 Results
4. WestChina-Frontier PharmaTech Awarded Full AAALAC Accreditation
5. WuXi PharmaTech (NYSE: WX) Mourns the Tragic Loss of Its Independent Director Shawn Wang
6. WuXi PharmaTech (NYSE: WX) Names Temporary Chairman of the Audit Committee
7. Princeton Professor David W. C. MacMillan Lectured WuXi PharmaTech Scientists
8. WuXi PharmaTech Announces Postponement of Proposed Follow-on Offering
9. Stanford Professor Barry M. Trost Visits WuXi PharmaTech and Gives Two Seminars
10. The First QPatch HT in China Placed in WuXi PharmaTech (NYSE: WX)
11. WuXi PharmaTech 2007 Annual Report Available Online
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... (PRWEB) September 18, 2014 Technology Association ... winners of its 2nd TAG Social Savvy Awards this ... Achievement’s Chick-fil-A Foundation Discovery Center in Downtown Atlanta. The ... , Turner Sports was honored with the 2014 ... year’s event also recognized innovators in 6 other award ...
(Date:9/18/2014)... A sold-out crowd of more than ... supported United Way of Westchester and Putnam ... event Monday, Sept. 15. Proceeds from the event will ... and Putnam, such as providing healthy foods to low-income ... risky behaviors like drug and alcohol usage. , Two ...
(Date:9/18/2014)... -- Teens and young adults who,ve been mentored may ... them with greater responsibility and independence early on in ... found that having a mentor provides a clear benefit ... Steve McDonald, an associate professor of sociology at North ... In conducting the study, published online recently ...
(Date:9/18/2014)... A common Asian spice and cancer-hampering molecules show ... cancer of the lung,s lining often linked to ... the Georg-Speyer-Haus in Frankfurt, Germany, demonstrate that application ... and cancer-inhibiting peptides increase levels of a protein ... cancer. Their findings appeared in the Aug. 14 ...
(Date:9/18/2014)... Research led by Paulo Rodriguez, PhD, an assistant research ... New Orleans, Stanley S. Scott Cancer Center, has identified ... plays in the body,s ability to fight cancer. Results ... activity and accumulation of cells that suppress the body,s ... research team showed that when they removed Chop, the ...
Breaking Medicine News(10 mins):Health News:Winners Honored at 2014 TAG Social Savvy Awards 2Health News:Winners Honored at 2014 TAG Social Savvy Awards 3Health News:United Way Celebrates “Best Chefs and Fine Wines” at Sold-Out Culinary Event 2Health News:United Way Celebrates “Best Chefs and Fine Wines” at Sold-Out Culinary Event 3Health News: Mentors May Steer Young People Toward More Rewarding Careers 2Health News:Curcumin, special peptides boost cancer-blocking PIAS3 to neutralize STAT3 in mesothelioma 2Health News:Curcumin, special peptides boost cancer-blocking PIAS3 to neutralize STAT3 in mesothelioma 3Health News:LSU Health research discovers means to free immune system to destroy cancer 2
... July 30 On Wednesday, July 30th,Representative Jose ... Act, a bill which, if passed, will remove ... spend federal funding that,they receive for prevention of ... method of HIV prevention which helps intravenous,drug users ...
... Company,s Fourth FDA 510(k) Clearance Since December 2007, ... Corp.,(Nasdaq: ESMC ) today announced that the ... the 510(k) submission for the LIASYS(TM),bench top clinical ... Diagnostic ("JAS") unit is the distributor,for the LIASYS ...
... CYT, MONTREAL, July 30 /PRNewswire-FirstCall/ - CryoCath ... products to treat cardiac,arrhythmias, today announced that Jan ... corporate update at the BMO Focus on Healthcare,Conference. ... at 8:30 a.m. (ET) in Room 2 at ...
... of Dr. Julius,Richmond, one of the founding fathers ... Americans who care about childhood education, health and ... (NHSA), the organization,representing children, family, educators and others ... education program., A statement issued today by ...
... travel to China for the 2008 Olympic Games, travelers ... bites, according to report by an Emory University travelers, ... Control and Prevention (CDC) and around the globe. ... rabies. The report finds that respiratory illnesses and dog ...
... American Association of Pharmaceutical Scientists (AAPS) will co-sponsor Immunogenicity ... , ... Horsham, PA ... (DIA) and the American Association of Pharmaceutical Scientists (AAPS) ...
Cached Medicine News:Health News:AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs 2Health News:AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs 3Health News:AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs 4Health News:AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs 5Health News:AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs 6Health News:AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs 7Health News:AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs 8Health News:AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs 9Health News:Escalon(R) Receives FDA 510(k) Clearance to Market the LIASYS(TM) Clinical Chemistry and Immunoturbidimetric Analyzer 2Health News:Escalon(R) Receives FDA 510(k) Clearance to Market the LIASYS(TM) Clinical Chemistry and Immunoturbidimetric Analyzer 3Health News:NHSA: Head Start Community Mourns Passing of Pioneer Dr. Julius Richmond 2Health News:Respiratory illnesses and dog bites a concern for travelers to China for 2008 Olympics 2Health News:DIA/AAPS Co-Sponsored Conference to Examine the Immunogenicity of Therapeutic Proteins 2
(Date:9/18/2014)... 2014 Just days before the government of ... contain the spread of Ebola, World Vision will begin a ... thanks to private donations. McKesson, the largest healthcare ... through its affiliate McKesson Medical-Surgical donated four million pairs of ... Sierra Leone,s needs for the next ...
(Date:9/18/2014)... MOUNTAIN VIEW, Calif. and CHESTERBROOK, Pa. ... (Nasdaq: VVUS ) and Auxilium Pharmaceuticals, ... the U.S. Food and Drug Administration (FDA) has approved a ... STENDRA is now the only FDA-approved erectile dysfunction (ED) medication ... before sexual activity. STENDRA is a prescription medication ...
(Date:9/17/2014)... /PRNewswire-iReach/ -- DeepResearchReports.com adds "2014 Market Research Report ... Market Research Report on Global and China Isothiocyanate ... Photo - http://photos.prnewswire.com/prnh/20140917/146748 ... Methacrylate (MMA) Industry" is a professional and in-depth ... and Global Methyl Methacrylate (MMA) market. The report ...
Breaking Medicine Technology:World Vision, McKesson, Other Donors Prepare for Massive Shipment of Medical Supplies to Support Sierra Leone Health Workers 2World Vision, McKesson, Other Donors Prepare for Massive Shipment of Medical Supplies to Support Sierra Leone Health Workers 3World Vision, McKesson, Other Donors Prepare for Massive Shipment of Medical Supplies to Support Sierra Leone Health Workers 4VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 2VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 3VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 4VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 5VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 6VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 7VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 8VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 9Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 2Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 3Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 4Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 5
A versatile plate washer and/or dispenser that aspirates from the top down without immersing the aspirating tubes in the well, ensuring overflow protection. 5 programmable protocols....
... High performance plus simple ... gentle and efficient washing ... is performed with minimum ... cells while membrane bound ...
Stat Fax 2600 is fully automatic microplate washer....
The Microtech Microplate Washer (220 V) is a flexible and ultra compact microplate washer. The system offers a wide choice of washing functions and sequences designed to handle most any microplate ap...
Medicine Products: